Core Viewpoint - Walgreens has launched Walgreens Weight Management, a digital healthcare program aimed at providing personalized, clinician-guided support for weight loss to eligible adults, expanding its Virtual Healthcare platform [1][4]. Group 1: Program Details - The program is designed for overweight and obese adults aged 18-64 who plan to self-pay for GLP-1 medication [1]. - Eligible patients can have online video consultations with licensed healthcare providers who will assess their health history and weight-related goals [2]. - The program includes on-demand follow-up visits for medication adjustments and side effect management, available daily from 7 a.m. to 11 p.m. CT [2]. Group 2: Pricing and Accessibility - Walgreens has introduced a reduced price for Novo Nordisk's Wegovy, starting at $149 per month for the 1.5 mg or 4 mg tablet and $199 per month for the 0.25 mg and 0.5 mg injectable [3]. - All visits under the Walgreens Weight Management program are priced at $49, with no monthly subscription required [5]. - The program is accessible in most states, allowing patients to send prescriptions to their preferred pharmacy [5][6]. Group 3: Market Context - Less than 25% of employers surveyed by KFF in 2025 cover GLP-1s for weight loss primarily for weight management, making Walgreens Weight Management a more affordable option for those without employer coverage [4].